Research Areas

A Multicenter, Double-Blind, Randomized, 12-Month, Placebo-Controlled Study to Evaluate the Lipid-Lowering Effect, Safety, and Tolerability of an Investigational Medication 25mg/Day and 50mg/Day When Added to Ongoing Stable Statin Therapy (HMG-CoA Reductase Inhibitors) in Patients With Primary Hypercholesterolemia

A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Efficacy and Tolerability of an Investigational Medication Co-Administered with Atorvastatin in Patients with Primary Hypercholesterolemia

A Multicenter, Randomized, Double-Blind, Titration Study to Evaluate the Efficacy and Safety of Ezetimibe Added on to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients with Hypercholesterolemia at Risk for Coronary Heart Disease

A Comparative Efficacy Study of An Investigational Medication and Lansoprazole in Patients with Erosive Esophagitis

A Phase 3, Randomized, Double Blind, Double Dummy, Parallel Group, Multicenter, Multinational Study for Evaluation of Efficacy and Safety of An Investigational Medication Versus Warfarin In Subjects with Atrial Fibrillation – Effective aNticoaGulation with factor xA next Generation in Atrial Fibrillation (ENGAGE-AF)

A Phase III, Randomized, Double-Blind, Active Control Trial to Evaluate the Safety and Efficacy of a Fixed Combination Metformin/Glyburide Product in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Maximum Dose Sulfonylurea Monotherapy

A 2-year, Randomized, Double-Blind, Parallel Group Study to Compare the Efficacy, Safety and Tolerability of Rosiglitazone Versus Placebo in Combination with Glipizide in Elderly Patients with Type 2 Diabetes Mellitus Who Are Inadequately Controlled on Glipizide Therapy and Who Are Intolerant to Metformin or Have a Contraindication to Metformin

Efficacy and Safety of Inhaled Human Insulin Therapy in Subjects with Type 2 Diabetes Mellitus Not Well Controlled with Combination Oral Agents: A Three-Month, Outpatient, Parallel Comparative Trial

Efficacy and Safety of Inhaled Compared with Subcutaneous Human Insulin Therapy in Subjects with Type 2 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial

A Double-Blind, Randomized Study of the Safety and Efficacy of a Combination of Metformin and 45mg of ACTOS (Pioglitazone HCI) Compared to a Combination of Metformin and 30mg of ACTOS (Pioglitazone HCI) in the Treatment of Patients with Type 2 (Non-Insulin Dependent) Diabetes Mellitus

A Multicenter, Randomized, Double-Blinded, Parallel-Group, Placebo-Controlled, Clinical Evaluation of an Investigational Medication in Combination with Current Insulin Therapy for 26 Weeks Duration in Subjects with Type 2 Diabetes Mellitus Who Are Inadequately Controlled with Insulin Alone

A Phase I-II Study of the Safety and Efficacy of Subcutaneous Administration of An Investigational Medication on Fasting Blood Glucose In Subjects With Type 2 Diabetes

Efficacy and Safety of Inhaled Compared with Subcutaneous Human Insulin Therapy in Subjects with Type 1 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial

An Open Label, Multicenter, Randomized, Parallel Group Study Comparing the Efficacy and Safety of An Investigational Insulin and Regular Human Insulin in Patients with Type 1 Diabetes Mellitus

A Phase I-II Study of the Safety and Efficacy of Subcutaneous Administration of an Investigational Medication on Fasting Blood Glucose in Subjects with Type 2 Diabetes

A Randomized, Placebo-Controlled, Double-Blind, Study to Evaluate the Safety and Efficacy of An Investigational Subcutaneously Administered Drug in Obese Subjects

A Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Four Doses of an Investigational Medication in Obese Patients

A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of An Investigational Medication Administered Orally Once Daily with A Reduced Calorie Diet in Obese Males and Females

A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Determine the Safety and Efficacy of An Investigational Medication in the Treatment of Obesity in Adults with Obesity-Related Co-Morbid Conditions

A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Determine the Safety and Efficacy of An Investigational Medication in the Treatment of Obesity in An Adult Population with BMI>35